Pursuant to Regulation 29 (l)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Roopa Industries has informed that a meeting of the Board of Directors of the Company scheduled to be held on Wednesday, 14th November, 2018, to consider and approve the Unaudited Financial Results / Unaudited Financial Statements for the Second quarter ended 30th September, 2018. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed from Tuesday, 6th November, 2018 and shall be opened 48 hours after the aforesaid financial results are approved by the Board of Directors on 14th November, 2018 and filed with the stock exchanges. All Insiders are informed to abstain from trading in the Company shares when the Trading Window is closed.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |